— Know what they know.
Not Investment Advice

PZOO OTC

Pazoo, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -90.0% 5Y: -99.3%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 50 · $26882 mcap · 2.69B float · 0.0011% daily turnover

Cash Flow Trends

Operating Cash Flow
-$905K +2.5% ▲
Capital Expenditures
$0 +0.0% ▲
Free Cash Flow
-$905K +2.5% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$16K -121.5% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2013FY2014FY2015FY2016FY2017
— Operating Activities —
Net Income-$658K-$5M-$4M-$9M-$4M
Depreciation & Amort.$2K$0$202K$187K$166K
Stock-Based Comp.$96K$1K$1M$80K$67K
Change in Working Capital$65K$23K$762K$2M$2M
Other Non-Cash Items$124K$4M-$10K$3M$684K
Operating Cash Flow-$373K-$1M-$2M-$928K-$905K
— Investing Activities —
Capital Expenditures$0$0-$312K$0$0
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0-$543K-$779K$0$0
Investment Sales$0$0$0$0$0
Other Investing$0-$543$20K$0$0
Investing Cash Flow$0-$543K-$1M$0$0
— Financing Activities —
Net Debt Issuance$84K$2M$1M$462K$71K
Stock Repurchased$0$0$0$0$0
Dividends Paid-$67K$0$0$0$0
Other Financing$262K$40K$1M$449K$818K
Financing Cash Flow$278K$3M$2M$1M$889K
Net Change in Cash-$95K$698K-$717K$72K-$16K
Cash End of Period$36K$734K$17K$89K$73K
Free Cash Flow-$373K-$1M-$2M-$928K-$905K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms